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Basic calcium phosphate crystal-induced collagenase production:
role of intracellular crystal dissolution
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Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, Milwaukee,
Wisconsin; and *Department of Medicine, The University of Miami, Veterans Affairs Medical Center,
Miami, Florida, U.S.A.
Summary
Objective: To investigate the potential therapeutic effects of inhibiting intracellular dissolution of basic calcium
phosphate (BCP) crystals in tissue culture by raising lysosomal pH using bafilomycin A1, a specific vacuolar pump
inhibitor.
Design: 45Ca-labeled crystals were used to demonstrate intracellular crystal dissolution in human foreskin fibroblasts
(HF). Mitogenesis was evaluated using [3H]thymidine incorporation assays and cell counts. Northern blot and Western
blot were used to study collagenase [matrix metalloproteinase-1 (MMP1)] mRNA accumulation and protein secretion,
respectively.
Results: Bafilomycin A1 inhibited intracellular dissolution of BCP crystals and caused a concentration-dependent
inhibition of BCP crystal-induced mitogenesis. Doses of bafilomycin A1 which inhibited intracellular crystal dissolution
and mitogenesis had no effect on BCP crystal-induced MMP1 mRNA accumulation or protein secretion.
Conclusion: Raising lysosomal pH to inhibit intracellular BCP crystal dissolution attenuates the proliferative
response to BCP crystals in HF but does not prevent metalloprotease synthesis and secretion. The therapeutic potential
of lysosomotropic agents for preventing joint destruction in BCP crystal deposition disease is limited.
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ation and structural destruction seen with BCP
deposition, as they engender a mitogenic response
in joint lining cells, promote synthesis and
secretion of proteases by articular cells, and elicit
release of cytokines that promote chondrolysis.
Since no therapy is currently available to deter
deposition of these crystals, inhibition of their
biological effects is an attractive strategy for
prevention of joint damage consequent to crystal
deposition. Understanding the mechanisms by
which BCP crystals cause mitogenesis and protease
secretion might suggest effective pharmacologic
interventions.
Inhibition of BCP crystal-induced mitogenesis in
synovial lining cells could theoretically reduce
joint damage by decreasing the number of cells
secreting cytokines and matrix-degrading en-
zymes. BCP crystals, in concentrations found in
pathologic human joint fluids, stimulate DNA
synthesis in and mitogenesis of quiescent cultured
human foreskin fibroblasts, canine synovial fibro-
blasts and adult porcine articular chondrocytes
[5, 6]. Control particles of similar size such as
diamond dust or latex beads do not stimulate
mitogenesis.
Introduction
Intra-articular basic calcium phosphate (BCP)
(hydroxyapatite, octacalcium phosphate, trical-
cium phosphate) crystal deposition disease is
clinically associated with severe degenerative
arthritis characterized by synovial lining hyper-
plasia and loss of intrasynovial collagenous
structures [1]. BCP crystals are present in 30–60% of
joint fluids from osteoarthritic (OA) knees [2]. The
presence of BCP crystals correlates strongly with
radiographic evidence of cartilage degeneration [3],
and is associated with larger joint effusions when
compared with joint fluid from OA knees without
crystals [4]. The BCP crystals themselves are at
least partly responsible for the synovial prolifer-
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Current evidence suggests that the mitogenic
response to BCP crystals requires crystal endocy-
tosis followed by dissolution in the acidic
environment of cellular phagolysosomes [7–10].
The resultant increase in cytoplasmic calcium
concentration presumably activates calcium-
dependent pathways which result in mitogenesis.
Both ammonium chloride and chloroquine, lysoso-
motropic agents which raise lysosomal pH,
significantly inhibit intracellular crystal dissol-
ution and consequently inhibit mitogenesis [7].
However, these lysosomotropic agents have mul-
tiple biologic effects, other than inhibition of
crystal dissolution, which may provide alternative
explanations for their inhibition of mitogenesis.
Chloroquine interferes with protein synthesis
in vitro and in vivo [11, 12]. By intercalation, it
inhibits DNA and RNA polymerase reactions
in vitro, and DNA replication and RNA transcrip-
tion in susceptible cells [13]. It impedes DNA
synthesis stimulated by platelet-derived growth
factor [14]. Ammonium chloride has been shown to
alter oxygen consumption, glycolysis and incorpor-
ation of labeled precursors into RNA and DNA
[15]. Although inconclusive, available data does
suggest that raising lysosomal pH could diminish
the proliferative response of cells which phago-
cytose BCP crystals.
Inhibition of BCP crystal-induced matrix metal-
loproteinase (MMP) release would also theoreti-
cally attenuate joint destruction in BCP
deposition disease. BCP crystals induce co-
ordinate synthesis and secretion of the MMP’s
collagenase and stromelysin in human fibroblasts
[16]. Secretion of these enzymes permits degra-
dation of many matrix components including type
II collagen, fibronectin, laminin and proteoglycan.
These two MMPs have been postulated to mediate,
at least in part, the joint destruction associated
with the presence of BCP crystals in synovial fluid.
Although intracellular crystal dissolution is im-
portant for BCP crystal-induced mitogenesis, its
role in BCP crystal-induced MMP production is
not known. Thus, the approach of raising
lysosomal pH to impede dissolution of BCP
crystals may have no effect on MMP synthesis and
secretion by phagocytic cells.
In these studies we investigated the potential
therapeutic effects of specifically inhibiting dissol-
ution of BCP crystals in tissue culture. Vacuolar-
type H+-ATPase is responsible for acidification in
vacuolar compartments such as lysosomes. A
specific inhibitor of vacuolar-type H+-ATPase,
bafilomycin A1 [17, 18], is a macrolide antibiotic
which inhibits acidification in lysosomes of
cultured cells. Other type ATPases are not affected
by this antibiotic. Its specificity contrasts with
that of ammonium chloride and chloroquine. Using
the model of mitogenesis and protease secretion in
cells phagocytosing BCP crystals, we studied the
effect of the specific vacuolar pump inhibitor,
bafilomycin A1. We found that raising lysosomal
pH to inhibit intracellular BCP dissolution
attenuates the proliferative response to BCP
crystals but does not prevent collagenase (MMP1)
synthesis and secretion. The therapeutic potential
of lysosomotropic agents for preventing joint
destruction in BCP crystal deposition disease
therefore appears limited to possible inhibition of
BCP crystal-induced synovial proliferation.
Materials and Methods
probes and reagents
The MMP1 probe was a 2.05-kb Hind III/Sma I
insert from the pC11ase 1 clone [19], obtained from
the repository of human DNA probes of the
American Type Culture Collection (Rockville, MD,
U.S.A.). The pHcGAP plasmid containing glyceral-
dehyde-3-phosphate dehydrogenase (GAPD) cDNA
[20] was also from the American Type Culture
Collection. Tritiated thymidine (3H-TdR; 50 Ci/
mmole) was from Amersham (Arlington Heights,
IL, U.S.A.). 45Ca was from DuPont NEN Research
Products (Boston, MA, U.S.A.). Bafilomycin A1 was
from Professor K. Altendorf (Universitat Os-
nabruck, Osnabruck, Germany). Latex beads
(particles both 0.460 and 1.16 mm in diameter) were
from Sigma Chemical Company (St. Louis, MO,
U.S.A.). Diamond dust (particles 1–5 mm long) was
obtained from A. Landau Co., (Philadelphia, PA,
U.S.A.). The MMP1 antibody was a polyclonal
antibody raised in rabbit against purified human
MMP1 from gingival fibroblasts, a kind gift of
Peter G. Mitchell, PhD (Pfizer Inc., Groton, CT,
U.S.A.). Biotin-labelled goat anti-rabbit IgG and
peroxidase-labelled streptavidin were from
Kirkegaard and Perry Laboratories, Inc. (Gaithers-
burg, MD, U.S.A.). Enhanced chemiluminescence
was performed using a kit from Amersham Life
Sciences, (Buckinghamshire, England). Tritiated
thymidine (50 Ci/mmol) was from Amersham Life
Sciences and a32P dATP was from ICN Pharmaceu-
ticals, Inc. (Irvine, CA, U.S.A.). Fetal bovine serum
(FBS), Hanks’ balanced salt solution (HBSS) and
DMEM were from Gibco (Grand Island, NY,
U.S.A.).
crystal synthesis and preparation
BCP and 45Ca trace-labeled BCP crystals were
synthesized by a modification of published methods
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[10]. Briefly, 15 ml of 0.2 m sodium phosphate
buffer, pH 6.7 was slowly added to 12.5 ml of 0.2 m
CaCl2 and stirred for an hour at room temperature.
The precipitate formed was centrifuged at low
speed and then washed twice with water. Twenty
microliters of 0.5 n HCl was added to the stirred
precipitate suspended in 2 ml water, and the pH
was adjusted to 08.5–10.0, with 20% NaOH. The
suspended precipitate was stirred overnight and
washed four times with water. The precipitate
was then washed once with absolute alcohol and
once with acetone, then dried in a vacuum
desiccator. Mineral prepared by this method had a
calcium:phosphate molar ratio of 1.59 and
contained partially carbonate-substituted hydrox-
yapatite (HA) with admixed octacalcium phos-
phate (OCP) shown by Fourier transform infrared
spectroscopy. The crystals were crushed and sieved
to yield 10–20 mm aggregates, which were sterilized
and rendered pyrogen free by heating at 200° C
for 90 min. Heating to 200° C did not alter
the crystal character or the relationship of HA
and OCP, as confirmed by X-ray diffraction and
Fourier transform infrared spectroscopy. Crystals
were weighed and suspended by sonication
in Dulbecco’s modified Eagle’s media (DMEM).
The amounts of crystals used were determined
based on our previous studies of dose–response
relationships between BCP crystals and the
mitogenic response [5]. In those studies, maximal
mitogenic responses were achieved with BCP
levels of 50–100 mg/ml. These levels are equivalent
to concentrations of BCP crystals found in
pathologic joint fluids. Monosodium urate mono-
hydrate crystals were prepared from twice-recrys-
tallized uric acid (Sigma Co., St. Louis, MO,
U.S.A.) and sodium hydroxide as previously
described [5] and heated to 180° C for 2 h to render
them pyrogen-free. The crystals were sonicated for
2 min before use to produce crystals 5–30 mm long
immediately before addition to cultures. For some
experiments, latex beads were suspended in
DMEM containing 10% FBS. Doses of all
particulates are expressed as units/per square
centimeter to reflect coverage of cells in culture.
cell culture
A model system of human foreskin fibroblasts
(HF) cultures were used for these experiments
since their responses to BCP crystals have been
shown to be similar to those of synovial fibroblasts
[5, 8]. HF cultures were established from explants
and transferred as previously described [21]. They
were grown and maintained in DMEM sup-
plemented with 10% FBS containing 1% penicillin,
streptomycin and Fungizone (PSF). All exper-
iments were performed on confluent cell monolay-
ers that had been rendered quiescent by removing
the media, washing with DMEM alone and
subsequently incubating in DMEM containing
0.5% FBS and 1% PSF for 24 h. All cultures used
were third- or fourth-passage cells.
determination of mitogenesis by uptake of
[3h]thymidine
Cells were grown to confluence in 24-well plates
and rendered quiescent by incubation in 0.5% FBS
for 24 h. [3H]thymidine (1 mCi/ml) was added to the
wells 23 h after the addition of 10% FBS or BCP
crystals (18 mg/cm2) in the presence or absence of
varying concentrations of bafilomycin A1, and
pulse-labeled for 1 h. Control cultures were in 0.5%
FBS with or without varying concentrations of
bafilomycin A1. The cells were then washed three
times with phosphate-buffered saline (PBS), and
macromolecules were precipitated with 5%
trichloroacetic acid (TCA) solution. The precipi-
tate was washed again with PBS and dissolved in
1 ml 0.1 n NaOH/1% sodium dodecyl sulfate (SDS).
Levels of TCA-precipitable 3H were determined in
triplicate, using a liquid scintillation counter
(Packard Instruments, Downers Grove, IL, U.S.A.).
In separate experiments, mitogenic stimulation of
monolayers was followed by trypsinization after
48 h and cell counts were determined using a
Coulter counter (Coulter Electronics, Hialeah, FL,
U.S.A.). Previous studies have demonstrated that
cell counts of BCP crystal-treated cultures deter-
mined by Coulter counter are consistent with
counts determined by hemocytometer and that
BCP crystals are minimally membranolytic [5].
determination of intracellular dissolution of
45ca-labelled bcp crystals
Intracellular dissolution of 45Ca-labelled crystals
was determined as described previously [10].
Briefly, confluent, quiescent HF cultures were
treated with varying concentrations of bafi-
lomycin A1, and then incubated with 45Ca-BCP
(25 mg/cm2) for 48 h. Control cultures were incu-
bated with 45Ca-labeled BCP crystals alone. To
account for nonspecific 45Ca release due to isotopic
exchange of crystal surface 45Ca with culture
media (CM), cell-free wells containing fresh media
were prepared and incubated similarly as a further
control. After 48 h, the amount of free 45Ca released
into CM was determined using a scintillation
counter. The adherent monolayers were then lysed
with 0.1 n NaOH. The cell-associated 45Ca-BCP,
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considered to represent undissolved crystals, was
dissolved using 0.1 n HCl and the radioactivity in
an aliquot of acidified cell lysate was measured to
determine the total cell-associated 45Ca. The per
cent release of 45Ca resulting from intracellular
dissolution of 45Ca-BCP, in the presence or absence
of various concentrations of bafilomycin A1, was
then calculated.
northern blot analysis
Northern blot analysis of total cellular RNA was
used to study the expression of MMP1 mRNA in
HF after stimulation with BCP crystals, MSU
crystals, latex beads or diamond dust. Confluent,
quiescent monolayer cultures of HF in 100-mm
plates were washed twice with cold PBS 24 h after
treatment. Total RNA was recovered by precipi-
tation with 4 m LiCl as described by Cathala et al.
[22]. Five micrograms of total cellular RNA was
fractionated on a 1.2% agarose–formaldehyde gel,
ribosomal RNA was visualized with ethidium
bromide, and the fractionated RNA was trans-
ferred to nitrocellulose filters [23]. Hybridization of
the filters with DNA probes was performed
overnight at 42 ° C. Probes were labeled using the
random primer method to a specific activity of
q5 · 108 cpm/mg [24]. The filters were washed at a
maximal stringency of 0.25 · standard saline cit-
rate (SSC; 1 · SSC = 0.15 m sodium chloride, 0.015 m
sodium citrate, pH 7.0) at 60° C for 30 min.
Autoradiography was performed with Kodak
XAR-5 film (Eastman Kodak, Rochester, NY,
U.S.A.) and signal intensity was quantified by
scanning laser densitometry (LKB Instruments,
Stockholm, Sweden).
immunoblotting
MMP1 secretion was confirmed by Western blot
[25]. Briefly, samples of CM from cultures treated
with BCP crystals, MSU crystals, latex beads,
diamond dust or unstimulated control cultures
were electrophoresed through 10% polyacrylamide
gels under reducing conditions and then trans-
ferred onto nitrocellulose membranes. After trans-
fer, the membranes were incubated in 2.5% non-fat
dry milk in Tris-buffered saline (TBS) (20 mm Tris,
500 mm NaCl, pH 7.5) to eliminate nonspecific
binding of the antibodies to the membranes. The
membranes were washed twice with Tween-20
wash solution (20 mm Tris, 500 mm Na Cl, 0.05%
Tween-20) (TTBS). The membranes were then
incubated with antibody buffer containing a 1:1000
dilution of anti-MMP1 antibody for 2 h at room
temperature. The blots were then washed with
TTBS and incubated with a 1:1000 dilution of
biotin-conjugated goat anti-rabbit IgG for 1 h.
This was followed by washing with TTBS and
incubation with a 1:1000 dilution of peroxidase-la-
beled streptavidin for 1 h. Membranes were
washed twice with TTBS and once with TBS.
Immunoreactive bands were detected using en-
hanced chemiluminescence reagents and auto-
radiography.
statistics
Statistical analysis was performed using the
Wilcoxon Rank Sum test [26].
Results
inhibition of bcp crystal-induced mitogenesis
by bafilomycin a1
The addition of 25 mg/cm2 BCP crystals in 0.5%
FBS-DMEM stimulated a fourfold increase in
[3H]thymidine incorporation, an index of mitogen-
esis, compared with that in cultures incubated
with 0.5% FBS alone after 24 h (Fig. 1). We
performed cell counts to confirm that the increased
[3H]thymidine uptake was accompanied by an
increase in cell number. The mean 2 s.d. number
of cells (· 106/8 cm2) in unstimulated control
cultures was 3.23 2 0.65 (Fig. 2). The number of
cells (· 106/8 cm2) in cultures incubated with BCP
Fig. 1. Inhibition of the mitogenic effects of basic
calcium phosphate (BCP) crystals by bafilomycin A1:
[3H]thymidine incorporation. Media in confluent cul-
tures of HF grown in 24-well plates was changed to
DMEM containing 0.5% FBS. Twenty-four hours later,
fresh DMEM containing FBS (0.5% or 10%), BCP
crystals (25 mg/cm2), with or without bafilomycin (at
varying concentrations), or bafilomycin alone was
added. After 23 h, all plates were pulse-labeled with
[3H]thymidine (1 mCi/ml) for 1 h. The plates were then
processed and thymidine incorporation was determined.
Results are expressed as [3H]thymidine uptake measured
in thousands. All values are given as the mean 2 s.e.m.;
n = 3; Baf, bafilomycin A1; (Q) alone; ( +10 nm Baf; (+)
+30 nm Baf; (,) +50 nm Baf.
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Fig. 2. Effect of bafilomycin A1 on 45Ca release from
45Ca-BCP by human fibroblasts (HF). Confluent, quies-
cent HF cultures were incubated with 45Ca-BCP crystals
(25 mg/cm2) in the presence or absence of bafilomycin A1
for 48 h as described in ‘Methods’. There was significant
difference in 45Ca release by HF vs cell-free wells,
P Q 0.01. There was significant difference in 45Ca release
by untreated HF vs HF treated with bafilomycin A1 (10,
30 or 50 nm), P Q 0.01. ( ) Cell-free media; (q)
HF-conditioned media.
into CM [10]. In the current investigation, we
demonstrated an approximately threefold increase
in release of 45Ca from 45Ca-BCP within 48 h after
treatment of monolayers of HF with BCP (25 mg/
cm2) when compared with isotopic exchange of 45Ca
with media in cell-free wells after 48 h (Fig. 2).
When monolayers were treated with bafilomycin
A1, there was significant inhibition of 45Ca release
into CM, an index of intracellular crystal
dissolution, at all concentrations tested. Inhibition
was similar at all concentrations tested. Concen-
trations used were those which caused inhibition
of mitogenesis.
Fig. 3. Effect of bafilomycin A1 on BCP crystal-induced
accumulation of MMP1 mRNA accumulation. Confluent
cultures of HF in 100-mm plates were incubated in
DMEM for 24 h. Some monolayers were treated with
bafilomycin A1 (10 or 30 nm) 30 min before treatment
with either BCP (18 mg/cm2) or 10% FBS. Control
cultures were in DMEM alone or containing 10% FBS
or BCP (18 mg/cm2). All plates were harvested after 24 h
and total RNA was isolated. Northern blot analysis was
performed using a specific cDNA probe for MMP1
(COLL), followed by autoradiography. The MMP1 probe
was then removed by washing, and the blot was
re-probed with glyceraldehyde-3-phosphate dehydrogen-
ase (GAPD) cDNA to ensure analysis of equivalent
quantities of total mRNA under each condition. The
positions of the 28S and 18S ribosomal bands are shown.
C, control unstimulated cultures; B, BCP; F, FBS; Baf,
bafilomycin, numbers refer to concentration (nm).
crystals was 4.21 2 0.11, a 30% increase over that
in control cultures. The mean 2 s.d. number of
cells (· 106/8 cm2) in cultures treated with 10% FBS
was 4.31 + 1.1, a 33% increase over control
cultures. Bafilomycin A1 inhibited the mitogenic
response of HF to BCP crystals in a concentration-
dependent fashion (Fig. 1) with equivalent (066%)
inhibition induced by bafilomycin A1 30 nm and
50 nm. Inhibition of BCP crystal-induced mitogene-
sis using bafilomycin A1 (50 nm) was associated
with a cell count of 2.96 + 0.35 · 106/8 cm2. The
inhibition of BCP crystal-induced mitogenesis is
not specific as bafilomycin A1 inhibited the
mitogenic response of HF to 10% FBS (Fig. 1).
However, there was only 37% inhibition of
FBS-induced mitogenesis with bafilomycin 50 nm,
the concentration which inhibited BCP crystal-in-
duced mitogenesis by 66%. Inhibition of 10%
FBS-induced mitogenesis using bafilomycin A1
(50 nm) was associated with a cell count of
3.25 + 0.49 · 106/8 cm2. When cells were incubated
with bafilomycin A1 alone in 0.5% FBS-DMEM,
there was a slight inhibition of [3H]thymidine
incorporation at 30 and 50 nm concentrations
(Fig. 1).
effect of bafilomycin a1 on
45ca release from
45ca-bcp by hf
We have previously suggested that HF solubilize
BCP crystals and that intracellular crystal
dissolution results in the release of free calcium
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effect of bafilomycin a1 on bcp
crystal-induction of mmp1 mrna
accumulation and protein secretion
BCP crystals induced significant accumulation
of MMP1 mRNA 24 h after stimulation (Fig. 3).
Doses of bafilomycin A1 which inhibited mitogene-
sis and intracellular crystal dissolution had no
effect on BCP crystal induction of MMP1 mRNA
accumulation 24 h after treatment. There was
minimal accumulation of MMP1 mRNA in HF
treated with 10% FBS and bafilomycin (10 nm) had
no effect on 10% FBS-induced MMP1 mRNA
accumulation. Similarly, analysis of CM from
HF monolayers by Western blot 48 h after
treatment with BCP crystals showed a significant
increase in the production of a doublet protein of
approximately 50 and 55 kDa, immunoreactive
with a polyclonal antibody to MMP1 (Fig. 4).
Treatment of cultures with bafilomycin A1 had no
effect on the secretion of MMP1 in response to
BCP crystals.
Fig. 5. Effect of non-mitogenic particulates on MMP1
protein secretion. Confluent, quiescent HF cultures
incubated in DMEM were stimulated with either BCP
crystals (18 mg/cm2), MSU crystals (9 or 18 mg/cm2), latex
beads [500 mg/ml (44 mg/cm2)] or DD (9 mg/cm2). Control
cultures were unstimulated. After 48 h, the CM was
analysed by Western blot, using a polyclonal antibody to
MMP1. The positions of the molecular weight markers
are shown. C, control; B, BCP; MSU, monosodium urate;
LB, latex beads; DD, diamond dust particles.
effect of non-mitogenic particulates on
collagenase mrna accumulation in and
protein secretion by hf
It has been reported that neither latex beads nor
diamond crystals induce mitogenesis in cultured
mammalian cells and MSU crystals are only
modestly mitogenic compared with BCP crystals
[5]. We studied the induction of MMP1 mRNA
accumulation in and protein secretion by HF
treated with latex beads (0.460 mm, 500 mg/ml
[44 mg/cm2)], diamond crystals (9 mg/cm2) or MSU
crystals (9 or 18 mg/cm2) compared with BCP
crystals (18 mg/cm2). Both BCP and MSU crystals
induced MMP1 mRNA accumulation in HF 24 h
after stimulation (data not shown). There was no
MMP1 mRNA accumulation in cultures in DMEM
with or without latex beads or diamond crystals
24 h after treatment. Both BCP and MSU caused
increased MMP1 protein secretion by HF 48 h after
treatment (Fig. 5). In contrast, neither latex beads
nor diamond dust caused MMP1 protein secretion.
‘Opsonization’ of latex beads with 10% FBS had no
effect, nor did variation of dosage [200 mg/ml
(18 mg/cm2)] or particle size (1.16 mm) (data not
shown).
Discussion
If dissolution of BCP crystals in the phagolyso-
somes were necessary for both the proliferative
response and the induction of MMP in articular
Fig. 4. Effect of bafilomycin A1 on BCP crystal-induced
MMP1 protein secretion. Confluent, quiescent HF
cultures incubated in DMEM were stimulated with
either BCP crystals (18 mg/cm2) or 10% FBS. Thirty
minutes before stimulation, some cultures were treated
with bafilomycin A1 (30 nm). Control cultures were
unstimulated or treated with bafilomycin A1 alone. After
48 h, the culture medium (CM) was analysed by Western
blot, using a polyclonal antibody to MMP1. The
positions of the molecular weight markers are shown. C,
control; B, BCP; 10% F, 10% FBS; Baf 30, bafilomycin A1
(30 nm).
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cells, then elevation of intralysosomal pH would
offer an attractive approach to prevention of the
destructive sequelae of BCP crystal deposition.
Endocytosis, followed by intracellular crystal
dissolution, appears to play an important role in
the mitogenic response to BCP crystals [7, 9]. Both
onset and peak [3H]thymidine incorporation in-
duced by BCP crystals are delayed 2–3 h compared
with onset and peak of cells stimulated with serum
[5]. This lag-time has been felt to represent the time
required for phagocytosis and intracellular dissol-
ution of crystals. The data described here confirm
the importance of intracellular dissolution, using
the proton pump inhibitor bafilomycin A1 to inhibit
intracellular dissolution of BCP crystals. Mitogen-
esis is not completely inhibited, however, consist-
ent with previous data from our laboratory which
demonstrated that BCP crystal-induced mitogene-
sis involves additional more rapid, cell membrane-
associated events such as protein kinase C (PKC)
activation [27] and induction of proto-oncogenes
such as c-fos and c-myc [28]. The effect of
bafilomycin A1 on BCP crystal-induced PKC
activation or gene expression has not been
evaluated. Our data suggest that therapeutically
targeting lysosomes would be expected to only
partially ameliorate the synovial proliferation
routinely seen in joints containing BCP crystals.
The mechanisms involved in the stimulation of
synthesis and secretion of MMP in response to
BCP crystals are unclear. The inhibition of crystal
dissolution by bafilomycin A1 had no effect on BCP
crystal-induced MMP1 mRNA accumulation or
protein secretion by human fibroblasts. These data
suggest that intracellular crystal dissolution of
BCP crystals plays an insignificant role in BCP
crystal induction of MMP1 and that lysoso-
motropic agents such as hydroxychloroquine
would not be expected to dramatically alter the
secretion of chondrolytic MMP in vivo. The effect
of bafilomycin A1 on BCP crystal-induction of
cytokines or other MMP has not been studied,
however.
Intracellular free calcium levels, as assessed by
the photoactive dye, Fura-2, have been shown to
rise quickly following exposure to BCP crystals,
consistent with influx of extracellular calcium and
release from intracellular calcium pools. Normal
intracellular calcium levels are restored within
8 min but are subsequently followed by a second,
slow rise in intracellular calcium, interpreted to
reflect intracellular calcium crystal dissolution
[29]. The effect of bafilomycin A1 on BCP
crystal-induced intracellular calcium flux is not
known.
Opsonization of BCP crystals could modulate
their biologic effects, but studies of BCP crystal-
induced mitogenesis are usually performed in the
presence of low dose serum only [5, 21]. Opsoniza-
tion of crystals using higher concentrations of
serum greatly interferes with mitogenesis and
induction of MMP since serum contains growth
factors and cytokines.
Although peripheral to our experimental ques-
tions, we were surprised to note that control
particles did not cause MMP production. Others
have shown that non-mitogenic particulates such
as latex beads added to rabbit synovial fibroblasts
in culture are phagocytosed and stimulate se-
cretion of collagenolytic activity into conditioned
media [30]. In an experiment using latex beads as
an anticipated positive control for MMP1 se-
cretion, we were unable to demonstrate induction
of MMP1 mRNA accumulation or protein se-
cretion when HF were treated under conditions
previously reported to elicit MMP1 release [30]. It
may be that in our culture system of human
fibroblasts, mitogenesis and MMP1 induction are
linked, in contrast to rabbit synovial fibroblasts,
reflecting cell-type differences. Alternatively, it is
possible that collagenase activity noted by others
resulted from proteases other than MMP1.
Although the mitogenic response of fibroblasts to
MSU crystals is minimal, MSU crystals activate
the cells to produce MMP, presumably by a
membranolytic effect [31].
Bafilomycin A1 inhibition of mitogenesis extends
beyond that induced by crystals. Bafilomycin A1
inhibited serum-induced mitogenesis in HF. This is
consistent with published data showing inhibition
of cell growth in mitogen treated or untreated
cells, including fibroblasts, in culture [32, 33]
Acidification of endosomes promotes dissociation
of many growth factors, including epidermal
growth factor (EGF), fibroblast growth factor
(FGF) and insulin, from their receptors. The
receptors may then be recycled to the plasma
membrane. Inhibition of acidification can in turn
inhibit such growth factor dissociation, and,
consequently, the mitogenic response to serum
growth factors.
BCP crystals have potent biologic activities all
of which are consistent with their association with
degenerative joint disease. The data presented
here further elucidates the mechanism of BCP
crystal-induction of MMP1. An increased under-
standing of the mechanisms underlying the
biological activitiy of BCP crystals is essential to
the development of rational therapy. Targeting
lysosomes with agents such as hydroxychloroquine
might partly alter the natural history of BCP
crystal deposition disease.
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